Professor Ángel Serrano, principal investigator at the
Biomaterials and Bioengineering Laboratory of the Catholic
University of Valencia (UCV), recently published an article in
journal ACS Nano, from the American Chemical Society, which shows
that carbon-based nanomaterials (CBNs) with low or zero toxicity
for humans, are “promising treatments” against the pneumonia caused
by COVID-19, as well as other viruses, bacteria and fungi,
including those that are multi-resistant to
medicines.